The research report on ‘biologics market’ includes an in-depth study on the latest developments across the market, new product development, trade regulations, and strategic moves by company players.
Description: The research report on ‘biologics market’ includes an in-depth study on the latest developments across the market, new product development, trade regulations, and strategic moves by company players. Technological trends, future growth prospects, global expansion opportunities, market restraints, growth drivers, and much more are also elaborated in detail in this report. It also offers a thorough understanding on the production volume and value of the market at global, domestic, and company levels.
Main: The worldwide biologics market size accounted for a revenue share of USD 281.69 billion in 2019 and is poised to amass substantial gains over 2020-2025. Elevating expansion of pipeline products and high economic growth aligned with increasing pervasiveness of chronic diseases are likely to spur the product demand globally. Moreover, expanding need for low cost biologics and medical services is touted to add to the global biologics market size expansion in the upcoming years.
Biologics market is segmented into product type, applications, and end user segments. Based on product type segmentation, the market is categorized into vaccines, monoclonal antibodies, recombinant hormones or proteins and others. Product applications include cancer, infectious diseases, and others. End user industries segment is subdivided into hospitals, clinics, diagnostic centers, and multiple others.
The industry trends across Asia Pacific, North America, and Europe are also enveloped in detail in the report. The market analysis further encompasses details on the competitive landscape of the industry, including the robust presence of top notch players, their growth tactics, and business share in the global surgical ophthalmology market.
Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/2515110/
Many of the prominent pharmaceutical companies across the globe have been making efforts to offer biologics which could address the demand of efficient, productive, and inexpensive medicine for all kinds of chronic untreatable diseases. Another crucial factor supporting the growth of biologics market size is the efficiency and safety of biologics medicine, and its potential to treat previously grave diseases.
Worldwide biologics market is categorized on the basis of vivid types including Monoclonal Antibodies, Recombinant Hormones and/or proteins, vaccines and multiple others. It has been estimated that Monoclonal Antibodies would gather massive traction across the global market in the upcoming years, owing to wide availability and development of medicines and technology which helps in biologics, in tandem with the viability of cost effective and proficient production process. This will be followed by recombinant hormones or proteins .
Furthermore, cancer applications across the application spectrum and hospitals in the end use segment have potentially secured significant market share, given the mounting investment by hospitals in offering high grade treatment for some long-term medical conditions like psoriasis, Crohn’s disease, rheumatoid arthritis, and others, along with an ever growing list of patients suffering from cancer.
Considering the regional landscape, North America secured a considerable market share in the global biologics market followed by Europe and Asia Pacific. This growth is ascribed to the increasing prevalence of chronic diseases including diabetes, cancer, stroke, heart disease, respiratory diseases, and multiple others in the North America region.
In addition to this, huge investment by various global manufacturers operating in the region, with an intent to garner more market share, have been forecast to bolster the biologics market size in the near future.
The biologics market is rather fragmented. In this competitive scenario, companies like Eli Lily and Company, Sanofi SA, Pfizer, Johnson & Johnson, Bristol-Myers Squibb Company, and others are engaging in M&As to augment their stance in the global market.
To access a sample copy or view this report in detail along with the table of contents, please click the link below:
The worldwide biologics industry is segmented on the basis of product type, applications, end user, regional demographics, and competitive landscape.
Biologics Market Product Type Analysis (Revenue, USD Million, 2015-2025)
- Vaccines
- Monoclonal Antibodies
- Recombinant Hormones/Proteins
- Cellular and Gene based
- Others
Biologics Market Application Analysis (Revenue, USD Million, 2015-2025)
- Cancer
- Rare and Auto-immune Diseases
- Infectious Diseases
- Others
Biologics Market End User Analysis (Revenue, USD Million, 2015-2025)
- Hospitals
- Clinics
- Diagnostic Centers
- Others
Biologics Market Region Analysis (Revenue, USD Million, 2015-2025)
Asia Pacific
- China
- Japan
- India
- South Korea
Europe
- Germany
- France
- UK
North America
- United States
- Canada
Biologics Market Competitive Landscape Analysis (Revenue, USD Million, 2015-2025)
- Eli Lily and Company
- Sanofi SA
- Pfizer
- Roche Holding AG
- AbbVie Inc
- Amgen Inc
- Merck & Co
- Novo Nordisk
- Bristol-Myers Squibb Company
- Johnson & Johnson
Related Report:
Wound Care Biologics Market Share & Forecast, 2019 – 2025
Wound Care Biologics Market will exceed USD 2.5 billion by 2025; as per a new research report. Rising geriatric population will also impact the wound care biologics market positively. Geriatric population is susceptible to chronic diseases that raises the demand for surgical procedures. Extensive usage of wound healing products in surgical and post-surgical procedures will substantially enhance wound care biologics market growth.
Venous leg ulcers segment was valued USD 195.0 million in 2018 and is expected to have enormous growth throughout the analysis period. Venous leg ulcers are often caused due to obstruction in the functioning of blood supply from legs to heart for purification.
About US:
Market Study Report, LLC. is a hub for market intelligence products and services. We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.
Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.
If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.
Contact Us:
Corporate Sales,
Market Study Report LLC
Phone: 1-302-273-0910
Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com